What was the trade-off between clinical benefits and harms considered by the committee?
The committee was not able to make a recommendation on the clinical and cost effectiveness of cardiac MRI in heart failure as no randomised controlled studies were found that addressed the review question. The committee decided to make a research recommendation to establish the added value of cardiac MRI (in terms of its clinical and cost effectiveness) in the clinical pathway of heart failure.